Health NewsComments Off on Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.